Anthony M Hunter
Emory University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Anthony M Hunter as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:29 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT07734077 · Revumenib in Patients With MyelofibrosisJohn Mascarenhas · not yet recruiting · Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:29 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Project 3: Development of Strategies to Deplete Myelofibrosis Stem CellsP01CA108671 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Ronald Hoffman · fiscal years 2006 to 2026Named on NCT07734077
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 00:29 UTC. The ranking covers the 200 most relevant of 38 PubMed records, and a shared surname and initials can bring in a namesake. All 38 on PubMed
- Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression.Clin Neurophysiol · 2009105 citationsRCR 3.4
- Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression.Brain Stimul · 201591 citationsRCR 3.9
- Six weeks of a polarized training-intensity distribution leads to greater physiological and performance adaptations than a threshold model in trained cyclists.J Appl Physiol (1985) · 201390 citationsRCR 4.0
- Cognitive rehabilitation group intervention for breast cancer survivors: results of a randomized clinical trial.Psychooncology · 201588 citationsRCR 3.3
- Role of pill-taking, expectation and therapeutic alliance in the placebo response in clinical trials for major depression.Br J Psychiatry · 201465 citationsRCR 2.6
- Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression.Am J Psychiatry · 200658 citationsRCR 1.8
- Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder.J Psychiatr Res · 201058 citationsRCR 2.0
- Periarticular Injection After Total Knee Arthroplasty Using Liposomal Bupivacaine vs a Modified Ranawat Suspension: A Prospective, Randomized Study.J Arthroplasty · 201658 citationsRCR 4.0
- Midline and right frontal brain function as a physiologic biomarker of remission in major depression.Psychiatry Res · 200947 citationsRCR 1.5
- Assessment of the feasibility of a rehabilitation intervention program for breast cancer survivors with cognitive complaints.Brain Imaging Behav · 201344 citationsRCR 1.7